Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients

The electrocardiogram (ECG) represents an essential tool to determine cardiac electrical abnormalities in COVID-19 patients, the effects of anti-SARS-CoV-2 drugs, and potential drug interactions. Smartphone-based heart monitors have increased the spectrum of ECG monitoring however, we are not aware...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaballos, Matilde, Fernández, Ignacio, Rodríguez, Lucia, Orozco, Silvia, García, Amparo, Juncos, Mónica, Alvarez-Zaballos, Sara, Piñeiro, Patricia, Hortal, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326027/
https://www.ncbi.nlm.nih.gov/pubmed/37415069
http://dx.doi.org/10.1038/s41598-023-37688-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326027/
https://www.ncbi.nlm.nih.gov/pubmed/37415069
http://dx.doi.org/10.1038/s41598-023-37688-8

Ejemplares similares